Publication | Open Access
Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia
32
Citations
57
References
2014
Year
Hematological MalignancyMedicinal ChemistryNovel Acylureidoindolin-2-one DerivativesMedicineAcute Myeloid LeukemiaMalignant Blood DisorderPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1